Ginkgo Bioworks COO Reshma Shetty transitions role; Jennifer Wipf assumes ops duties

Ginkgo Bioworks Holdings, Inc.

Dr. Reshma Shetty steps down as COO effective Jan 1, 2026; remains President and Board member.
She will focus on expanding autonomous lab for cell engineering service offerings.
CEO Dr. Jason Kelly assumes principal operating officer oversight duties.
Jennifer Wipf (ex-CCO/GM) takes on day-to-day operations, reporting to Kelly.
Wipf brings vaccine and plant management experience from over a decade at Merck.

item 5.02item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.